Brief: VYNE Therapeutics Q2 Basic EPS USD -0.22
14/08/2024 13:00
Aug 14 (Reuters) - VYNE Therapeutics Q2 EPS from cont ops USD -0.22. * Q2 revenue USD 198 thousand * Q2 net income USD -9.406 million
YARW — YARROW BIOSCIENCE News Story
0.000.00%
Last trade - 00:00- $181.86m
- $158.94m
- $0.57m